Rotavirus vaccine 116E - Bharat Biotech

Drug Profile

Rotavirus vaccine 116E - Bharat Biotech

Alternative Names: 116E - Bharat Biotech; Oral Rotavirus Vaccine 116E Live Attenuated - Bharat Biotech; ORV-116E; Rotavac; Rotavac - Bharat Biotech; ROTAVAC 5CM; Vero cell-based 116E neonatal rotavirus vaccine - Bharat Biotech

Latest Information Update: 12 Dec 2016

Price : $50

At a glance

  • Originator Bharat Biotech
  • Class Rotavirus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Rotavirus infections

Most Recent Events

  • 05 Dec 2016 Bharat Biotech plans a phase III trial for Rotavirus infections (In infants, Prevention) in India (PO) (CTRI2016-11-007481)
  • 09 Mar 2015 Launched for Rotavirus infections (In infants, Prevention) in India (PO)
  • 01 May 2014 Bharat Biotech initiates enrolment in a phase IV trial for Rotavirus infections (healthy infants; prevention) in India (CTRI2014-04-004548)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top